ASX:BB1

2 stories mentioning ASX:BB1

Every FINWIRES story that references ASX:BB1, newest first.

BlinkLab Enters Academic Research Agreement With Dutch Research Center

BlinkLab (ASX:BB1) entered into an academic research agreement with Erasmus University Medical Center in the Netherlands to investigate treatment-related changes in behavioral and neurodevelopmental function in patients with Activated PI3K Delta Syndrome, a rare disorder associated with neurodevelopmental and behavioral symptoms, including autism, according to a Tuesday Australian bourse filing.The study evaluates behavioral and neurodevelopmental function before and during treatment with a selective PI3Kδ inhibitor, a pathway-targeted therapy in the syndrome.

ASX:BB1

Asia60d ago

BlinkLab Generates Nearly AU$18 Million From Share Placement; Shares Down 3%

BlinkLab (ASX:BB1) generated a gross AU$17.5 million from an oversubscribed share placement at a price of AU$0.65 per ordinary share, according to a Thursday filing with the Australian bourse.Members of the company's board and management participated in the placement with a commitment to contribute AU$200,000.The healthcare company will use the funds to complete a US registrational trial for autism diagnosis using its Dx1 platform while also supporting the lead product's approval processes in Europe.Additionally, BlinkLab plans launch a second clinical program in the US using its Dx2 platform as a diagnostic aid for attention-deficit/hyperactivity disorder, or ADHD.Shares of the company were down 3% in recent Thursday trade.

ASX:BB1